Neuroscience

New blood marker can identify Parkinsonian diseases

In a study by researchers at Lund University the marker DOPA decarboxylase (DCC) was found to be elevated in individuals with Parkinson's disease as well as in people with other diseases that result in dopamine deficiency ...

Diseases, Conditions, Syndromes

Developing a test for long COVID 'brain fog'

Two blood biomarkers could be predictive of cognitive deficits six and 12 months after a diagnosis of COVID-19, reports a new study published in Nature Medicine. These findings, based on data from more than 1,800 patients ...

Alzheimer's disease & dementia

Blood-based biomarkers for Alzheimer's disease: Study in China

Discrepancies in diagnostic biomarkers for Alzheimer's Disease (AD) may arise from racial disparities, risk factors, or lifestyle differences. Moreover, there has been a lack of systematic and multicenter studies to evaluate ...

Alzheimer's disease & dementia

Researchers present new guidelines for diagnosing Alzheimer's

Today at the International Alzheimer's Congress (AAIC) in Amsterdam, new guidelines for diagnosing Alzheimer's disease developed by clinicians and researchers from around the world were presented. In these criteria, the disease ...

Diseases, Conditions, Syndromes

Developing better diagnostic tools for tuberculosis

Many of us believe that tuberculosis has been eradicated, but this is not the case. In large parts of the world, tuberculosis is the infectious disease that takes most lives.

page 3 from 24